News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Eli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho’s Jared HolzEli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho’s Jared Holz
News

Eli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho’s Jared Holz

February 29, 2024
Introducing the Mizuho Corporate Culture AwardIntroducing the Mizuho Corporate Culture Award
News

Introducing the Mizuho Corporate Culture Award

February 28, 2024
Baidu’s latest results are ‘very respectable,’ analyst saysBaidu’s latest results are ‘very respectable,’ analyst says
News

Baidu’s latest results are ‘very respectable,’ analyst says

February 28, 2024
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared HolzZealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz
News

Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

February 26, 2024
Mizuho welcomes 2023 Mizuho Americas Open Champion Rose Zhang as brand ambassadorMizuho welcomes 2023 Mizuho Americas Open Champion Rose Zhang as brand ambassador
Press Release

Mizuho welcomes 2023 Mizuho Americas Open Champion Rose Zhang as brand ambassador

February 26, 2024
Capital One and Discover merger could pose risks to Visa and Mastercard, says Dan DolevCapital One and Discover merger could pose risks to Visa and Mastercard, says Dan Dolev
News

Capital One and Discover merger could pose risks to Visa and Mastercard, says Dan Dolev

February 21, 2024
Coinbase rally is setting itself up for a bigger fall when it reports, says Mizuho’s Dan DolevCoinbase rally is setting itself up for a bigger fall when it reports, says Mizuho’s Dan Dolev
News

Coinbase rally is setting itself up for a bigger fall when it reports, says Mizuho’s Dan Dolev

February 10, 2024
Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared HolzAmgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz
News

Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz

February 9, 2024
Health care’s underperformance last year sets it up well for 2024, says Mara GoldsteinHealth care’s underperformance last year sets it up well for 2024, says Mara Goldstein
News

Health care’s underperformance last year sets it up well for 2024, says Mara Goldstein

February 8, 2024
back-to-top-blue